Cellular Senescence Network (SenNet):Technology Projects (UG3/UH3 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is announcing a funding opportunity for the Cellular Senescence Network (SenNet): Technology Projects (UG3/UH3 Clinical Trial Not Allowed), aimed at small businesses. This initiative seeks to advance understanding of cellular senescence and its implications for health and disease by developing innovative tools and technologies to identify and characterize senescent cells, ultimately facilitating the creation of senotherapeutic strategies. With an estimated total program funding of $6 million and approximately 15 awards anticipated, interested applicants are encouraged to prepare collaborative proposals ahead of the expected application solicitation, which will be published in October 2025, with a closing date in December 2025. For further inquiries, potential applicants can contact Ajay Pillai at ajay.pillai3@nih.gov or by phone at 301-538-4811.